HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$1.58
Day range
$1.52 - $1.63
Year range
$0.62 - $2.50
Market cap
25.66M USD
Avg Volume
157.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 11.43M | 44.22% |
Net income | -12.36M | -142.87% |
Net profit margin | — | — |
Earnings per share | -0.81 | -55.77% |
EBITDA | -10.99M | -46.80% |
Effective tax rate | -1.16% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.93M | -60.64% |
Total assets | 26.26M | -60.71% |
Total liabilities | 32.66M | -15.89% |
Total equity | -6.40M | — |
Shares outstanding | 16.43M | — |
Price to book | -3.36 | — |
Return on assets | -86.62% | — |
Return on capital | -155.52% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -12.36M | -142.87% |
Cash from operations | -12.84M | -201.13% |
Cash from investing | 13.52M | 208.89% |
Cash from financing | 589.00K | 36.03% |
Net change in cash | 1.26M | 119.02% |
Free cash flow | -9.27M | -417.92% |
About
Founded
2015
Website
Employees
14